SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CTSO

Cytosorbents Corp (NASDAQ:CTSO)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$4.16-$0.97 (-18.91%)
 
Market cap
$13.1M
Insider Score
Health Score
Analyst consensus
Listed since
Aug 8, 2006
Market Cap$13.11M-74.9%
Revenue (ttm)$37.46M+1.3%
Net Income-$16.88M-59.4%
EPS-$5.33-43.7%
Shares Out3.15M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume28,692
Open$4.52
Previous Close$5.13
Day's Range$4.16 - $4.79
52-Week Range$2.84 - $17.00
Beta1.48
AnalystsBuy
Price Targetn/a
Earnings DateMar 24, 2027
-14.81% (1D)
No price history available.

About CTSO

Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. Their core expertise lies in a unique blood purification platform, built upon a proprietary adsorbent and porous polymer technology. The company's leading product, CytoSorb, is an extracorporeal filter designed to remove cytokines from the blood. It serves as a complementary treatment in various critical care scenarios, including sepsis, managing complications during and after heart bypass surgery, and improving the viability of donor organs for transplantation. Beyond CytoSorb, Cytosorbents offers a portfolio of specialized devices. These include VetResQ, used to assist in treating critical conditions like sepsis and pancreatitis in animals; CytoSorb-XL, another device targeting sepsis and other severe illnesses; HemoDefend, a platform for purifying blood supplies by removing contaminants that cause transfusion reactions and diseases, as well as anti-A and anti-B antibodies from blood products; K+ontrol, designed for patients with severe, life-threatening hyperkalemia; and ContrastSorb, which extracts intravenous contrast agents following imaging procedures (like CT scans, angiograms, or interventional radiology) to mitigate the risk of contrast-induced kidney damage. The company is also actively developing several new solutions: BetaSorb, aimed at preventing and treating complications from metabolic toxin buildup in chronic kidney disease patients; DrugSorb, which focuses on eliminating harmful chemicals from the bloodstream; and DrugSorb-ATR, an innovative system for removing antithrombotic agents. Originally established as MedaSorb Technologies Corporation in 1997, the company adopted its current name, Cytosorbents Corporation, in May 2010. Its corporate headquarters are situated in Princeton, New Jersey.

Address
305 College Road East, Princeton, NJ, 08540, US
Market Cap
13 million
Employees
129
Industrial Classification
Medical - Devices

Cytosorbents Corp Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
78th Percentile Overall Score
CTSO InsiderScore:85 / 99

Cytosorbents Corp scored higher than 78% of companies evaluated by InsiderBuying, and ranked 10th out of 52 stocks in the healthcare sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Cytosorbents Corp bought $120.4K of stock across 7 purchases in the last 90 days, the largest of them $70.0K.

Stake Increase

The average purchase added about 7% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$269.33K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Distressed
From CTSO’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-18.91%
5 Days
-13.69%
1 Month
-30.78%
6 Months
-54.88%
1 Year
-74.91%

$CTSO stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CTSO holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CTSO's directors and management

Net Shares Purchased by Insiders−400k−200k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CTSO Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CTSO Revenue by Segment or Geography

$9.73MTotal
SEGMENT INFORMATION$9.73M99.93%
(Gain) loss on foreign currency transactions$7.00K0.07%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CTSO patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CTSO from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CTSO

VTIVanguard Morningstar Total Stock Market ETF$227.95K
VXFVanguard Extended Market ETF$130.40K
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF$20.66K
MSSMMorgan Stanley Pathway Funds - Small-Mid Cap Equity ETF$4.29K
STSBiShares Factors US Small Blend Style ETF$1.23K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CTSO’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
83.26
Analyst Ratings
32% of score
60
News & Sentiment
20% of score
72

News check: Operating cash flow breakeven achieved in Q3 with positive financing activity and regulatory progress; concrete operational milestone outweighs modest capital raise.

Recent Insider Activity

Buys
10
Sells
0
Buy Value
$269.33K
Distinct Buyers
4

Insider Score Trend Over Time

+35.6 since Sep 24
0255075100Sep 24 — Insider Score 47.7Sep 25 — Insider Score 96.6Sep 26 — Insider Score 96.6Sep 27 — Insider Score 96.7Sep 28 — Insider Score 96.6Sep 29 — Insider Score 96.4Sep 30 — Insider Score 96.3Oct 1 — Insider Score 96.0Oct 2 — Insider Score 51.0Oct 3 — Insider Score 95.8Oct 4 — Insider Score 95.7Oct 5 — Insider Score 95.7Oct 6 — Insider Score 95.5Oct 7 — Insider Score 95.4Oct 8 — Insider Score 95.4Oct 9 — Insider Score 95.4Oct 10 — Insider Score 95.3Oct 11 — Insider Score 95.4Oct 12 — Insider Score 95.4Oct 13 — Insider Score 95.3Oct 14 — Insider Score 95.2Oct 15 — Insider Score 95.2Oct 16 — Insider Score 95.2Oct 17 — Insider Score 95.1Oct 18 — Insider Score 95.2Oct 19 — Insider Score 94.8Oct 20 — Insider Score 94.7Oct 21 — Insider Score 94.6Oct 22 — Insider Score 94.5Oct 23 — Insider Score 94.5Oct 24 — Insider Score 94.5Oct 25 — Insider Score 94.4Oct 26 — Insider Score 94.5Oct 27 — Insider Score 94.5Oct 28 — Insider Score 94.5Oct 29 — Insider Score 94.3Oct 30 — Insider Score 93.8Oct 31 — Insider Score 93.7Nov 1 — Insider Score 93.7Nov 2 — Insider Score 93.7Nov 3 — Insider Score 93.5Nov 4 — Insider Score 93.2Nov 5 — Insider Score 92.7Nov 6 — Insider Score 92.2Nov 7 — Insider Score 91.9Nov 8 — Insider Score 92.0Nov 9 — Insider Score 92.1Nov 10 — Insider Score 91.5Nov 11 — Insider Score 91.1Nov 12 — Insider Score 90.4Nov 13 — Insider Score 89.5Nov 14 — Insider Score 88.9Nov 15 — Insider Score 89.0Nov 16 — Insider Score 88.8Nov 17 — Insider Score 87.7Nov 18 — Insider Score 86.4Nov 19 — Insider Score 85.1Nov 20 — Insider Score 84.3Nov 21 — Insider Score 83.2Nov 22 — Insider Score 83.3Sep 24Oct 23Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.16%

Weight is the stock’s share of each fund’s holdings.